Biora Therapeutics, Inc.(BIOR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BIOR Biora Therapeutics, Inc.

Market Closed 12-20 16:00:00 EST Delay

{"stockData":{"symbol":"BIOR","market":"US","secType":"STK","nameCN":"Biora Therapeutics, Inc.","latestPrice":0.6,"timestamp":1734728400000,"preClose":0.627,"halted":0,"volume":105825,"delay":15,"floatShares":3200000,"shares":4423068,"eps":-35.648276,"marketStatus":"Market Closed","change":-0.027,"latestTime":"12-20 16:00:00 EST Delay","open":0.6,"high":0.64,"low":0.3201,"amount":56071.20839000001,"amplitude":0.510207,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-35.648276,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1734944400000},"marketStatusCode":7,"adr":0,"exchange":"PINK","adjPreClose":0.627,"volumeRatio":1.9456630094028506},"requestUrl":"/m/hq/s/BIOR/wiki","defaultTab":"wiki","newsList":[{"id":"2490604173","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2490604173","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490604173?lang=en_us&edition=fundamental","pubTime":"2024-12-11 02:14","pubTimestamp":1733854462,"startTime":"0","endTime":"0","summary":"CervoMed  said Tuesday that a phase 2b trial assessing neflamapimod to treat people with dementia with Lewy bodies failed to meet its primary or key secondary endpoints.Shares slumped 77% as intraday trading volume soared to over 6.44 million from a daily average of about 122,000.MEDIROM Healthcare Technologies  shares tumbled 45% amid heavy trading after the company unveiled late Monday an offering of 2.86 million American Depositary Shares at $1.75 each, targeting gross proceeds of about $5 million.More than 1.51 million shares traded intraday compared with a daily average of about 117,000.Biora Therapeutics  said in a regulatory filing Tuesday that Nasdaq has determined to delist its securities for failing to comply with the market value of listed securities requirement.Shares sank 60%, with intraday trading volume at over 1.39 million versus a daily average of about 88,000.Price: 2.36, Change: -7.89, Percent Change: -76.98","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7108","BK4196","MRM.AU","BK4192","MRM","BK4139","CRVO","BIOR"],"gpt_icon":0},{"id":"2490011508","title":"Dow Falls 150 Points; Oracle Posts Downbeat Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2490011508","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490011508?lang=en_us&edition=fundamental","pubTime":"2024-12-10 22:49","pubTimestamp":1733842164,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b0976596a01a7c781ec83559b443d7ed","isJumpTheme":false,"source_url":"https://www.benzinga.com/24/12/42415162/dow-falls-150-points-oracle-posts-downbeat-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","QID","BK4534","SQQQ","LU1069347547.HKD","LU0648001328.SGD","CMRX","BK4196","NQmain","PCOM","LU1935043023.USD","LU0719512351.SGD","MNQmain","QLD","PSQ","LU1489326972.SGD",".IXIC","BK4007","LU0861579265.USD","IE0009356076.USD","LU0082616367.USD","LU0289960550.SGD","LU0417517546.SGD","ORCL","BK4557","LU0889565833.HKD","LU0965508806.USD","IE00B19Z3B42.SGD","IE00BMPRXR70.SGD","LU2250418816.HKD","LU0965509101.SGD","CRVO","LU0208291251.USD","LU0476273544.USD","BIOR","LU0444971666.USD","CPIX","LU1934455863.HKD","MRM","LU0348723411.USD","QURE","LU1934455194.USD","LU1935042991.SGD","LU2054465674.USD","LU0985489474.SGD","LU1935042488.USD","TQQQ","LU1506573853.SGD","LU0256863811.USD"],"gpt_icon":1},{"id":"2490616018","title":"Investors Look Ahead to Key Inflation Data as US Futures Tread Water in Tuesday's Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2490616018","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490616018?lang=en_us&edition=fundamental","pubTime":"2024-12-10 21:16","pubTimestamp":1733836616,"startTime":"0","endTime":"0","summary":"US stock futures are treading water in Tuesday's premarket session as investors look ahead to key inflation data coming out Wednesday morning, including the monthly and weekly consumer price index and","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ISBC","CPIX","BK7108","NQmain","BK4211","TRNR","BK4196","BK4583","MRM","BK4557","RADX","BK4192","BK4007","BK4139","CMRX","MRM.AU","BIOR","BK4190"],"gpt_icon":0},{"id":"2490609436","title":"Biora Therapeutics Inc - Nasdaq to Delist Biora Therapeutics Due to Non-Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2490609436","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490609436?lang=en_us&edition=fundamental","pubTime":"2024-12-10 20:01","pubTimestamp":1733832103,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nFWN3NB0YC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIOR","BK4196"],"gpt_icon":0},{"id":"2484601219","title":"Biora Therapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2484601219","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484601219?lang=en_us&edition=fundamental","pubTime":"2024-11-19 02:08","pubTimestamp":1731953280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BIOR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 18, 2024 13:08 ET (18:08 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOR","LENZ"],"gpt_icon":0},{"id":"2483772371","title":"Biora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483772371","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483772371?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:01","pubTimestamp":1731679291,"startTime":"0","endTime":"0","summary":"Biora Therapeutics Inc reports results for the quarter ended September 30 - Earnings SummaryBiora Therapeutics Inc BIOR.OQ reported a quarterly adjusted loss of $5.04 per share for the quarter ended S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL8N3MM12X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOR"],"gpt_icon":0},{"id":"2483380225","title":"Highbridge Capital Management, Llc Reports 9.99% Passive Stake in Biora Therapeutics Inc as of Sept 30, 2024- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2483380225","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483380225?lang=en_us&edition=fundamental","pubTime":"2024-11-14 23:03","pubTimestamp":1731596611,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nFWN3ML0RD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","BK4139","BIOR"],"gpt_icon":0},{"id":"2483870475","title":"BRIEF-Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483870475","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483870475?lang=en_us&edition=fundamental","pubTime":"2024-11-14 21:18","pubTimestamp":1731590329,"startTime":"0","endTime":"0","summary":"Nov 14 (Reuters) - Biora Therapeutics Inc   :   * BIORA THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS THIRD QUARTER 2024 FINANCIAL RESULTSSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOR","BK4139","BK4196","LENZ"],"gpt_icon":0},{"id":"2483877330","title":"Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483877330","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483877330?lang=en_us&edition=fundamental","pubTime":"2024-11-14 21:00","pubTimestamp":1731589203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nTUA17K733:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIOR","BK4196"],"gpt_icon":0},{"id":"2483098667","title":"Biora Therapeutics Inc  expected to post a loss of $3.85 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2483098667","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483098667?lang=en_us&edition=fundamental","pubTime":"2024-11-13 08:03","pubTimestamp":1731456191,"startTime":"0","endTime":"0","summary":"Biora Therapeutics Inc  expected to post a loss of $3.85 a share - Earnings Preview Biora Therapeutics Inc BIOR.OQ BIOR.O is expected to show a rise in quarterly revenue when it reports  results on No","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nL8N3MK017:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOR"],"gpt_icon":0},{"id":"2481483188","title":"Biora Therapeutics Inc  expected to post a loss of $3.85 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2481483188","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481483188?lang=en_us&edition=fundamental","pubTime":"2024-11-08 23:52","pubTimestamp":1731081120,"startTime":"0","endTime":"0","summary":"Biora Therapeutics Inc  expected to post a loss of $3.85 a share - Earnings Preview Biora Therapeutics Inc BIOR.OQ BIOR.O is expected to show a rise in quarterly revenue when it reports  results on No","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL8N3MF26S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOR"],"gpt_icon":0},{"id":"2481315762","title":"Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2481315762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481315762?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:30","pubTimestamp":1731015000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUAYTL1C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","BK4139","BIOR"],"gpt_icon":0},{"id":"2481160353","title":"Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2481160353","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481160353?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:30","pubTimestamp":1731015000,"startTime":"0","endTime":"0","summary":"A replay will remain available for 60 days on the company’s website.About Biora TherapeuticsBiora Therapeutics is a clinical-stage biotech company developing two smart pill-based therapeutics platforms: the NaviCap platform for colon-targeted treatment of IBD, designed to improve patient outcomes through treatment at the site of disease in the gastrointestinal tract, and the BioJet platform for oral delivery of large molecules, designed to replace injection with needle-free, oral delivery.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/t64IRG7Tl2D2ujODNpY_lA--~B/aD00Nzc7dz0xNDczO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0877597311ae53204cffb0d12060da61","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/t64IRG7Tl2D2ujODNpY_lA--~B/aD00Nzc7dz0xNDczO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0877597311ae53204cffb0d12060da61"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biora-therapeutics-report-third-quarter-213000967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4196","LENZ","BK4139","BIOR"],"gpt_icon":0},{"id":"2479284746","title":"Biora Therapeutics Plans $3 Million Registered Direct Offering; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2479284746","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479284746?lang=en_us&edition=fundamental","pubTime":"2024-10-29 22:55","pubTimestamp":1730213707,"startTime":"0","endTime":"0","summary":"Biora Therapeutics  said Tuesday that it has agreed to sell 745,342 common shares at $4.025 per share in a registered direct offering.The company said it will issue unregistered warrants for the same number of shares in a private placement, with an exercise price of $3.90, which will be usable upon issuance and expire five years later.Gross proceeds are expected to be about $3 million. Net proceeds will be used for operations, further development of oral biotherapeutics, working capital, and general corporate purposes, the company added.The offering is set to close around Tuesday, pending customary conditions.Shares of Biora Therapeutics fell more than 16% in recent trading activity.Price: 3.70, Change: -0.72, Percent Change: -16.29","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4196","BK4139","LENZ","BIOR"],"gpt_icon":0},{"id":"2479640152","title":"Biora to sell 745,342 shares at $4.025 in registered direct offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2479640152","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479640152?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:31","pubTimestamp":1730205081,"startTime":"0","endTime":"0","summary":"Biora Therapeutics (BIOR) entered into definitive agreements for the purchase and sale of 745,342 shares of the Company’s common stock at an offeri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biora-to-sell-745342-shares-at-4-025-in-registered-direct-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biora-to-sell-745342-shares-at-4-025-in-registered-direct-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOR","BK4196","BK4139"],"gpt_icon":0},{"id":"2479409058","title":"BRIEF-Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2479409058","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479409058?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:24","pubTimestamp":1730204686,"startTime":"0","endTime":"0","summary":"Oct 29  - Biora Therapeutics Inc   :   * BIORA THERAPEUTICS ANNOUNCES $3 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES   * BIORA THERAPEUTICS INC - ANNOUNCES DIRECT OFFERING OF 745,342 SHARES   * BIORA THERAPEUTICS INC - TO ISSUE WARRANTS FOR 745,342 SHARES AT $3.90 EACHSource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU2210149790.SGD","BK4139","LU2210150020.SGD","MNQmain","LENZ","QID","SQQQ","IE00B3QW5Z07.USD",".IXIC","BIOR","NDAQ","IE00BGHQF748.EUR","NQmain","BK4588","PSQ","TQQQ","BK4112","BK4196","IE00BKPKM429.USD","BK4585","QLD","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2479788405","title":"Biora Therapeutics Inc - to Issue Warrants for 745,342 Shares at $3.90 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2479788405","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479788405?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:00","pubTimestamp":1730203204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nTUABJSNMQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","BIOR","BK4139"],"gpt_icon":0},{"id":"2479405465","title":"Biora Therapeutics Announces $3 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2479405465","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479405465?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:00","pubTimestamp":1730203204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nTUABJSNMQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIOR","BK4139","BK4196"],"gpt_icon":0},{"id":"2479240578","title":"Biora Therapeutics Inc - Announces Direct Offering of 745,342 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2479240578","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479240578?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:00","pubTimestamp":1730203204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nTUABJSNMQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIOR","BK4196"],"gpt_icon":0},{"id":"2479406555","title":"Press Release: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2479406555","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479406555?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:00","pubTimestamp":1730203200,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Oct. 29, 2024  -- Biora Therapeutics, Inc. , the biotech company reimagining therapeutic delivery, today announced that it has entered into definitive agreements for the purchase and sale of 745,342 shares of the Company's common stock at an offering price of $4.025 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to 745,342 shares of common stock. The warrants have an exercise price of $3.90 per share, will be exercisable upon issuance, and will expire five years following issuance. The closing of the offering is expected to occur on or about October 29, 2024, subject to the satisfaction of customary closing conditions.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139",".IXIC","BK4555","TM","IE00BGHQF748.EUR","BK4099","IE00B3QW5Z07.USD","LU2210150020.SGD","TQQQ","03160","LENZ","IE00BKPKM429.USD","MNQmain","PSQ","NDAQ","QLD","SQQQ","BK4112","BK4196","BK4588","QID","IE00B64PRP62.GBP","LU2095319765.USD","BK4585","NQmain","LU2210149790.SGD","BIOR"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.progenity.com","description":"Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and Systemic oral delivery platform for oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.","exchange":"PINK","name":"Biora Therapeutics, Inc.","nameEN":"Biora Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biora Therapeutics, Inc.(BIOR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biora Therapeutics, Inc.(BIOR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biora Therapeutics, Inc.,BIOR,Biora Therapeutics, Inc.股票,Biora Therapeutics, Inc.股票老虎,Biora Therapeutics, Inc.股票老虎国际,Biora Therapeutics, Inc.行情,Biora Therapeutics, Inc.股票行情,Biora Therapeutics, Inc.股价,Biora Therapeutics, Inc.股市,Biora Therapeutics, Inc.股票价格,Biora Therapeutics, Inc.股票交易,Biora Therapeutics, Inc.股票购买,Biora Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biora Therapeutics, Inc.(BIOR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biora Therapeutics, Inc.(BIOR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction